Cargando...
Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancer
There is firm evidence that PSA velocity is statistically associated with many prostate cancer outcomes, including those related to early detection. But clinical use of a marker depends on clinical as well as statistical significance. Before using PSA velocity to inform decisions such as whether or...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4054698/ https://ncbi.nlm.nih.gov/pubmed/23486455 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|